A股異動 | 天合光能(688599.SH)漲超4% 擬與通威股份下屬公司共同投資高純晶硅等多個項目
格隆匯11月18日丨天合光能(688599.SH)現報17.39元,漲4.19%,最新總市值359億元;通威股份(600438.SH)亦漲超3%。天合光能昨晚發公告稱,公司與通威股份下屬永祥股份、通威太陽能分別簽署合資協議,擬成立項目公司並共同投資:年產4萬噸高純晶硅項目,投資額約40億元;年產15GW拉棒項目,投資額約50億元;年產15GW切片項目及年產15GW高效晶硅電池項目,投資額約60億元。公司在各項目公司中參股比例均為35%,合計註冊資本金出資額21億元。此外,公司擬向通威股份下屬公司採購多晶硅產品約7.2萬噸。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.